PRL and neoplasm: In the case of the mildly hyperprolactinemic patient on DA with sign/symptom resolution and whose tumor size is controlled, it is unclear if there is a tangible medical benefit to be gained by further up-titrating DA to achieve strictly numerically normal prolactin levels.